• The total number of prevalent cases of chronic kidney disease across the countries under study will increase by 23% from 72 million in 2016 to 89 million in 2036.
  • Across the countries considered in this report, 75% of those with stage 5 CKD are receiving dialysis.
  • The prevalence of anemia increases by CKD stage, from 8% of stage 1 cases to 77% of stage 5 cases.

There is substantial variation in the prevalence of chronic kidney disease among the countries under study, ranging from 102 per 1,000 in Spain to 159 per 1,000 in Japan in 2016.

Table of contents

  • Chronic Kidney Disease - Epidemiology - Mature Markets Data

Author(s): Joseph Granato, MPH

Joseph Granato joined Decision Resources Group in 2012 and previously worked on both Market Access and Global Market Access products.  Joseph is currently responsible for forecasting the prevalence and incidence of disease populations throughout the world.  He is also tasked with identifying at risk populations and developing new epidemiological methods used to predict overall population health.

He received his M.P.H. from Des Moines University where he worked on several population health projects including the delivery of continuing medical education on tick-borne diseases.  He also holds a B.S. in Animal Science from the University of Tennessee.  Prior to his time with DRG Joseph worked with the Monroe County Health Department on the surveillance of reportable diseases including Dengue Fever.